Owner ViRexx Medical Corp.

Inventors Rajan, George; Noujaime, Antoine

Agent Pizzeys

Pub. Number AU-A-2008291604

PCT Pub. Number WO2009/026723

Priority 60/968,978 30.08.07 US

Filing date 29 August 2008

Wipo publication date 5 March 2009

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07K 14/02 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells